Experience Sharing on Healthcare Facility Commissioning | Abstract
Immunome Research

Immunome Research
Open Access

ISSN: 1745-7580


Experience Sharing on Healthcare Facility Commissioning

Alicia Wu Mingshu*, Max Liang Yerong, Callister Matthew and Wen Qingping

The uncontrolled proliferation of aberrant cells in the body is known as cancer. May affect any body tissue and take many distinct forms in different parts of the body. Damaged cells proliferate, divide, and spread abnormally instead of self-destructing as they should resulting in cancer. When a cell is severely injured and unable to heal itself, it goes through a process known as apoptosis, or programmed cell death. Cancer is that disease that can grow in any part of the body. One of the most common cancers in women is breast cancer and for men is prostate cancer. Both men and women are affected by lung cancer and colorectal cancer in large numbers. The growing body of knowledge about cancer's development and progression can be exploited to generate more precise diagnostics and/or less hazardous cancer treatments.With the artificial information is advancing, cancer treatment is becoming more precise and accurate, likewise, with cutting edge technology, healthcare facilitate can be equipped more effectively to support healthcare provider to work more efficiently, however, new healthcare facility commissioning process should be safety and quality-oriented activities which validate and document the performance of not only facility but system as well, during the process commissioning team will verify to see if the original or defined objective and criteria are met.

Published Date: 2021-09-24; Received Date: 2021-08-23